
Health Minister Adel Adawy said on Saturday that the ministry would give priority of applying a new hepatitis C virus (HCV) treatment on patients who suffer acute infection.
Addressing a press conference Saturday, the minister said Sovaldi drug would be given to patients who suffer long infection with the deadly virus.
Sovaldi’s success rate with hepatitis C patients was over 90 per cent, said the minister, adding the government would not spare effort to provide new drugs to the patients.
Also, the higher committee of combating tumors set the special regulations of cancerous tumors' treatments, he said.
Rates of people who catch the liver viruses are steadily increasing, the minister said, adding the new drug would be available in September.
GMT 10:31 2018 Tuesday ,13 November
Russian police uproot 70 underground drug labs in past six monthsGMT 16:32 2018 Tuesday ,06 November
Rwanda aims to achieve universal access to clean water by 2024GMT 16:57 2018 Sunday ,04 November
Palestinian women witness higher cure rate of breast cancerGMT 13:11 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 10:44 2018 Tuesday ,23 October
Scientists find microplastics in human stool for first timeGMT 09:18 2018 Tuesday ,23 October
US judge upholds Monsanto weedkiller cancer verdict, reduces payoutGMT 14:22 2018 Friday ,19 October
Birth spacing ‘improving health of Omani women’GMT 15:40 2018 Monday ,15 October
Pakistani president launches nationwide anti-measles driveMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor